Showing results (151-160 of 437) with videos related to
Sort By:
Pageof 44
Frontiers in Oncology|August 28, 2020
Deubiquitinating Enzyme: A Potential Secondary Checkpoint of Cancer ImmunityXing Huang, Xiaozhen Zhang, Jian Xu, et al.Cell & Bioscience|June 12, 2026
CRISPR diagnostics: from trans-nuclease activity to cancer diagnosisLei Chang, Wenjue Xu, Xiaoyan Wang, et al.Journal of Nanobiotechnology|July 31, 2025
Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinomaWanyue Cao, Kai Yang, Gaowei Jin, et al.Pharmacological Research|October 21, 2025
Amino acid sensing in cancerZihao Lin, Lihong He, Jiawei Wang, et al.Nature|March 20, 2025
Oncolytic virus VG161 in refractory hepatocellular carcinomaYinan Shen, Xueli Bai, Qi Zhang, et al.Journal of the American College of Surgeons|February 29, 2016
Roles of Sphincter of Oddi Laxity in Bile Duct Microenvironment in Patients with Cholangiolithiasis: From the Perspective of the Microbiome and MetabolomeTingbo Liang, Wei Su, Qi Zhang, et al.Oncotargets and Therapy|August 5, 2021
Gallbladder Adenosquamous Cancer with Situs Inversus Totalis: A Case Report and Literature ReviewJunming Huang, Hanjin Yang, Meng Wang, et al.Studies in Health Technology and Informatics|January 25, 2024
Whole-Liver Based Deep Learning for Preoperatively Predicting Overall Survival in Patients with Hepatocellular CarcinomaChao Huang, Peijun Hu, Yu Tian, et al.Journal of Nanobiotechnology|February 18, 2022
Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapyMeng Wang, Qida Hu, Junmin Huang, et al.Journal for Immunotherapy of Cancer|March 15, 2022
Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axisTianyu Tang, Xing Huang, Gang Zhang, et al.Pageof 44